Antonio F. Cruz

Antonio F. Cruz

Chief Executive Officer at TRANSITION THERAPEUTICS INC

71 year
Health Technology
Finance
Health Services

Profile

Founder of Angiotech Pharmaceuticals, Inc. and Transition Therapeutics, Inc., Antonio F.
Cruz
holds the position of Chief Executive Officer at Transition Therapeutics, Inc. and Chairman & Chief Executive Officer for NeuroMedix, Inc. Dr. Cruz is also on the board of Treat U SA, Accel-Rx and Mercal Capital Corp.
In his past career Antonio F.
Cruz
was President & Chief Executive Officer of Canadian Arthritis Network, Director & Vice President at Angiotech Pharmaceuticals, Inc. and Senior Scientist at Mount Sinai Hospital (Canada).

Antonio F. Cruz active positions

CompaniesPositionStart
TRANSITION THERAPEUTICS INC Chief Executive Officer 1998-07-05
Chief Executive Officer -
Director/Board Member -
Director/Board Member 2015-08-30
Director/Board Member -
All active positions of Antonio F. Cruz

Former positions of Antonio F. Cruz

CompaniesPositionEnd
Canadian Arthritis Network President 2000-12-31
Director/Board Member -
Chief Tech/Sci/R&D Officer -
Founder -
░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Antonio F. Cruz's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Antonio F. Cruz's experience

Connections

31

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Canadian Arthritis Network

Commercial Services

Health Technology

Health Technology

Finance

Finance

See company connections
  1. Stock
  2. Insiders
  3. Antonio F. Cruz